Zeniff Reyes

Prof. Zeniff Reyes

Biochemistry of metabolic disease laboratory, Universidad Juárez Autónoma de Tabasco, Villahermosa, Tabasco, Mexico
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
DMDalila Rubí Mena-Hernández
Dalila Rubí Mena-Hernández
GJGuadalupe Jiménez-Domínguez
Guadalupe Jiménez-Domínguez
JMJosé D. Méndez
José D. Méndez
VOViridiana Olvera
Viridiana Olvera
MMMirian Carolina Martínez-López
Mirian Carolina Martínez-López
JBJorge Ble-Castillo
Jorge Ble-Castillo
This study aimed to evaluate the effect of early time-restricted eating (eTRE) on metabolic markers and body composition in individuals with overweight or obesity. Seventeen subjects completed a randomized, crossover, and controlled clinical trial. Twelve women and five men participated, with a mean age of 25.8 ± 10.0 years and a BMI of 32.0 ± 6.3 kg/m2. The eTRE intervention included 16 h of fasting (3:00 pm to 7:00 am) and 8 h of ad libitum eating (7:00 am to 03:00 pm) (16:8). The trial included four weeks of interventions followed by a four-week washout period. Body weight, waist and hip circumferences, and body composition measurements were taken. Additionally, a venous blood sample was collected for biochemical determinations. In a before–after analysis, eTRE induced a reduction in BW and BMI in women but this was not significant when compared to the control group. eTRE did not modify any other anthropometric measurements, fasting biochemical parameters, glycemic and insulinemic responses, blood pressure, or subjective appetite. In conclusion, eTRE did not induce beneficial effects on the glycemic and lipid metabolisms, body composition, subjective appetite, or blood pressure. These findings may be attributed to the special characteristics of the population and the short intervention period.

7 October 2024 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
ZRZeniff Reyes
Zeniff Reyes
VOViridiana Olvera
Viridiana Olvera
Meztli Ramos-GarciaMeztli Ramos-Garcia
Meztli Ramos-Garcia
JMJosé D. Méndez
José D. Méndez
Crystell Guadalupe Guzmán PriegoCrystell Guadalupe Guzmán Priego
Crystell Guadalupe Guzmán Priego
JBJorge Ble-Castillo
Jorge Ble-Castillo
Sucralose stands as the most common non-nutritive sweetener; however, its metabolic effects have sparked significant controversy over the years. We aim to examine the effects of sucralose daily intake on glycemia, subjective appetite, and gut microbiota (GM) changes in subjects with overweight or obesity. In this randomized, crossover, and controlled trial, 23 participants with a body mass index between 25 kg/m2 and 39.9 kg/m2 will be assigned to one of two interventions to receive either sucralose (2 mg/kg/day equivalent to 40% of the acceptable daily intake) or glucose (control) for 4 weeks, each phase separated by a 4-week washout period. The glycemic response will be determined during a meal tolerance test, subjective appetite will be evaluated using a visual analog scale, and GM changes will be analyzed by next-generation sequencing of the bacterial rRNA 16S gene from fecal samples. All measures will be performed before and after intervention periods. We hypothesize that sucralose supplementation induces changes in glycemic response, subjective appetite, and gut microbiota in overweight and obese participants. This protocol was approved by the Ethics Committee of the UJAT (No. 0721) and was registered in the Australian New Zealand Clinical Trials Registry (ACTRN12621001531808).